Results 261 to 270 of about 3,949,650 (302)

Repeated administrations of dopamine receptor agents affect lithium-induced state-dependent learning in mice

Journal of Psychopharmacology, 2009
M. Zarrindast, F. Madadi, S. Ahmadi
semanticscholar   +1 more source

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Marsela Braunstein, Amit M Oza, Stephanie Lheureux   +2 more
exaly  

The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors

Psychopharmacology, 1999
Wei Zhang, F. Bymaster
semanticscholar   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek Kunle Owonikoko, Nabil F Saba   +2 more
exaly  

Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter.

European Journal of Pharmacology, 1996
I. Gordon, R. Weizman, M. Rehavi
semanticscholar   +1 more source

An update on larynx cancer

Ca-A Cancer Journal for Clinicians, 2017
Kristin A Higgins, Nabil F Saba
exaly  

Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents.

Journal of Medicinal Chemistry, 1997
S. Meegalla, K. Plössl, M. Kung, S. Chumpradit, D. A. Stevenson, Steven A. Kushner, W. Mcelgin, P. Mozley, H. Kung   +8 more
semanticscholar   +1 more source